Clean Label Supplements - Claims and Market Opportunities

November 20, 2014 2014-11-20 00:00:00 2014-11-20 00:00:00 America/New_York Clean Label Supplements - Claims and Market Opportunities 16:00 - 17:00 CET

16:00 - 17:00 CET

Market Segment: Dietary Supplement

Did you know that over one-third of supplements launched in Western Europe last year featured a clean label claim such as ‘no allergens’ or ‘gluten free’? Consumers are becoming increasingly aware about the quality and origin of their food supplements and how they are manufactured. Consumers are looking for products that have clearer and cleaner labels, and, various health authorities are beginning to respond. 
 
Please join Capsugel in partnership with Innova Marketing Insights to examine this important topic and help branded companies better understand and leverage this unique market opportunity.  

• Innova Market Insights Market Analyst Yasemin Özdemir will provide an in-depth summary of the clean label supplement market utilizing years of consumer and product trend information
• Capsugel regulatory expert Kathleen Jacobs will provide meaningful background to the new FIC Regulation and how this may influence product positioning and new product innovation within the supplement industry​

This one-of-a-kind webinar from Capsugel will educate marketers and provide valuable insight as you finalize brand programs for 2015 and develop new product initiatives.

See the webinar here:

Hard to Swallow? Novel Solutions for Pediatrics and Patients who can't swallow pills.

November 20, 2014 2014-11-20 00:00:00 2014-11-20 00:00:00 America/New_York Hard to Swallow? Novel Solutions for Pediatrics and Patients who can't swallow pills. 14:00 - 15:00 EST (11:00 - 12:00 PST)

14:00 - 15:00 EST (11:00 - 12:00 PST)

Market Segment: Pharmaceutical

This webinar will review a new capsule and multiparticulate formulation approach that best meets key concerns for safety, patient compliance, and in-vivo performance across a variety of patient cohorts.

Speakers:

• Matt Richardson, Phd, Manager Pharmaceutical Business Development - Capsugel
• Chris Diorio, Director R&D - Capsugel
• Missy Lowery, MS, Senior Manager Marketing - Capsugel

Register here

Inhalation Drugs in Capsule based Inhaler Systems: Optimizing DPI capsules on Formulation-Capsule-Device Interactions

November 19, 2014 2014-11-19 00:00:00 2014-11-19 00:00:00 America/New_York Inhalation Drugs in Capsule based Inhaler Systems: Optimizing DPI capsules on Formulation-Capsule-Device Interactions 10:00 AM - 11:00 AM ET (16:00 - 17:00 CET)

10:00 AM - 11:00 AM ET (16:00 - 17:00 CET)

Market Segment: Pharmaceutical

Dry Powder Inhalation (DPI) is a leading drug delivery technology for the treatment of respiratory diseases, and increasingly for systemic drug delivery. Optimizing a DPI capsule is not an easy task; understanding the relationship between the device, formulation and capsule is key to improve drug performances. 

Four industry experts will provide insight into state-of-the-art technologies for inhalation drug development:

• Capsugel will share the unique know-how gained from more than 20 years of experience in specialized inhalation capsules.
• Bend Research, a division of Capsugel Dosage Form Solutions, will discuss expertise in formulation and particle engineering with spray drying technology.
• Aptar, a key player in capsule-based expedients, will describe how the capsule-based devices are a simple and cost-effective way to deliver medication via the pulmonary route, and why these types of devices are the future of inhalation technology.

Speakers:

• Dominique Cadé, Director Polymer Science, Research and Development - Capsugel
• Frédérique Bordes-Picard, Pharmaceutical Business Development Manager EMEA - Capsugel
• Dr. Gerallt Williams, Director Scientific Affairs - Aptar Pharma
• Eduardo Jule, PhD, Senior Manager Business, Market and Product Development - Capsugel

See the webinar here:

Bioavailability Enhancement Webinar Series - Optimizing Technology Choice to Enhance Bioavailability

September 30, 2014 2014-09-30 00:00:00 2014-09-30 00:00:00 America/New_York Bioavailability Enhancement Webinar Series - Optimizing Technology Choice to Enhance Bioavailability 8:00 AM - 9:00 AM PT (17:00 - 18:00 CET)

8:00 AM - 9:00 AM PT (17:00 - 18:00 CET)

Market Segment: Pharmaceutical

An increasing number of active compounds in pipelines today have properties that require functional formulation to enable exposure and efficacy. Despite many new technology choices, it is often difficult to match the right drug-delivery technology to a given molecule and problem statement. This problem is exacerbated by the need to save time and valuable drug in early development. This webinar describes an efficient strategy for mating enabling drug-delivery technologies with problem statements based on challenging compound properties and product concepts, building on an understanding of gut physiology, key molecule physicochemical properties, and the target product profile.

Speaker:
David Lyon, Ph. D., Senior Vice President, Bend Research

Moderator:
David Vodak, Ph. D., Vice President, Bend Research

See the webinar here:

Novel Solutions for Pediatrics and Patients with Swallowing Difficulties

September 24, 2014 2014-09-24 00:00:00 2014-09-24 00:00:00 America/New_York Novel Solutions for Pediatrics and Patients with Swallowing Difficulties 10:00 AM - 11:00 AM ET (16:00 - 17:00 CET)

10:00 AM - 11:00 AM ET (16:00 - 17:00 CET)

Market Segment: Pharmaceutical

To overcome the many challenges associated with pediatric and patient-centric drug development, Capsugel is offering a new generation of technologies for product development that combines the benefits and flexibility of multi-particulate formulations, lipid-based technologies, and capsule delivery. Proprietary Lipid Multi-Particulate (LMP) technology offers a range of functionality (taste / odor masking, bioavailability enhancement, controlled release, ...) applicable to many formulation challenges. Combined with Coni-Snap® sprinkle capsules, specifically designed to be easily opened in order to allow drugs to be taken in soft foods, LMP technology can offer premier performance in pediatric formulations.

Speaker:
Richard Hart, Business Development Manager, EMEA - Capsugel

Moderator:
Catherine Lehmann, Senior Marketing Manager, EMEA - Capsugel

See the webinar here: